Literature DB >> 17991554

Correlation between primary tumor pathologic features and presence of clinical metastasis at diagnosis of testicular seminoma.

Juan P Valdevenito1, Ivan Gallegos, Cristina Fernández, Cristian Acevedo, Rodrigo Palma.   

Abstract

OBJECTIVES: To compare several risk factors in the testicular biopsy of patients with pure seminoma with and without clinical metastasis at diagnosis.
METHODS: We performed a retrospective study of patients with pure seminoma. The retroperitoneum was staged with computed tomography and the thorax with simple radiography and/or computed tomography, taking into account the original reports and clinical stage. The previous reports and original pathology plates were reviewed by pathologists who were unaware of the clinical stage of the patients. Patients with beta-human chorionic gonadotropin greater than 800 mUI/mL were excluded.
RESULTS: A total of 86 patients had sufficient data and comprised the study cohort. Of the 86 patients, 62 had clinical Stage I (72%), 20 had Stage II (23%), and 4 had Stage III (5%). On univariate analysis, tumor size greater than 4 cm (P = 0.0135), testicular vascular invasion (P = 0.0042), rete testis invasion (P = 0.0002), tunica albuginea penetration (P = 0.00001), base of the spermatic cord invasion (P = 0.0002), epididymis invasion (P = 0.001), and vascular invasion of the cord (P = 0.024) were predictive of metastasis. On multivariate analysis, tumor size greater than 6 cm (odds ratio 6.9, 95% confidence interval 1.3 to 35, P = 0.02) and rete testis invasion (odds ratio 6.1, confidence interval 1.2 to 30, P = 0.025) remained as important predictors of metastasis (tumor size less than 6 cm was not significant on multivariate analysis).
CONCLUSIONS: The results of this study have demonstrated that rete testis invasion and tumor size correlate independently with the presence of clinical metastasis at diagnosis of testicular seminoma.

Entities:  

Mesh:

Year:  2007        PMID: 17991554     DOI: 10.1016/j.urology.2007.05.020

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  15 in total

1.  Evaluation of germ-cell neoplasia in situ entity in testicular tumors.

Authors:  Mehmet Akyüz; Ramazan Topaktaş; Ahmet Ürkmez; Orhan Koca; Metin İshak Öztürk
Journal:  Turk J Urol       Date:  2018-03-16

2.  Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.

Authors:  Xue-Cheng Bi; Jiu-Min Liu; Hui-Chang He; Yong-Kang Ye; Zhao-Dong Han; Qi-Shan Dai; Yu-Xiang Liang; Chao Cai; Jia-Hong Chen; Xi-Bin Chen; Guo-Qiang Qin; Guo-Hua Zeng; Wei-De Zhong
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

3.  Testicular germ cell tumors: the changing role of the pathologist.

Authors:  Andrea Ronchi; Francesca Pagliuca; Renato Franco
Journal:  Ann Transl Med       Date:  2019-09

4.  Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?

Authors:  Vincenzo Favilla; Giorgio Ivan Russo; Fabio Spitaleri; Daniele Urzì; Marco Garau; Massimo Madonia; Alberto Saita; Furio Pirozzi Farina; Sandro La Vignera; Rosita Condorelli; Aldo E Calogero; Sebastiano Cimino; Giuseppe Morgia
Journal:  Int Urol Nephrol       Date:  2013-12-07       Impact factor: 2.370

5.  Total embedding of spermatic cord and hilar soft tissue in orchiectomy for seminoma: does the extensive sampling improve pathologic risk factors?

Authors:  Maurizio Colecchia; Biagio Paolini; Giacomo Maria Pini; Laura Carpenito; Beatrice Maghini; Barbara Avuzzi; Anna Maria Paganoni; Nicola Nicolai
Journal:  Virchows Arch       Date:  2022-07-01       Impact factor: 4.064

Review 6.  Biomarkers of disease recurrence in stage I testicular germ cell tumours.

Authors:  Peter Lesko; Michal Chovanec; Michal Mego
Journal:  Nat Rev Urol       Date:  2022-08-26       Impact factor: 16.430

7.  [Testicular tumors. Predictive factors].

Authors:  G Mikuz
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

8.  Prediction of metastatic status in non-seminomatous testicular cancer.

Authors:  C G Ruf; S Sachs; N Khalili-Harbi; H Isbarn; W Wagner; C Matthies; V Meineke; M Fisch; F K Chun; M Abend
Journal:  World J Urol       Date:  2013-10-29       Impact factor: 4.226

9.  Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.

Authors:  Kazuhiro Kobayashi; Toshihiro Saito; Yasuo Kitamura; Tomohiro Nobushita; Takashi Kawasaki; Noboru Hara; Kota Takahashi
Journal:  Diagn Pathol       Date:  2013-04-08       Impact factor: 2.644

10.  Treatment of stage I seminoma: is it time to change your practice?

Authors:  Darren R Feldman; George J Bosl
Journal:  J Hematol Oncol       Date:  2008-11-07       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.